Clinical and Vaccine Immunology : Cvi

Overview

Clinical and Vaccine Immunology : Cvi is a scientific journal, published by American Society for Microbiology since 2006 in English. The journal's country of origin is United States and its primary focus areas are pathology and allergy & immunology.

Details

Abbr. Clin Vaccine Immunol

Publisher American Society for Microbiology

Start 2006

End 2017

Frequency Monthly

p-ISSN 1556-6811

e-ISSN 1556-679X

Country United States

Language English

Specialties Pathology
Allergy & Immunology

Recent Articles

11.

A Single Intramuscular Dose of a Plant-Made Virus-Like Particle Vaccine Elicits a Balanced Humoral and Cellular Response and Protects Young and Aged Mice from Influenza H1N1 Virus Challenge despite a Modest/Absent Humoral Response

Hodgins B, Yam K, Winter K, Pillet S, Landry N, Ward B

Clin Vaccine Immunol . 2017 Oct; 24(12). PMID: 29021303

Virus-like-particle (VLP) influenza vaccines can be given intramuscularly (i.m.) or intranasally (i.n.) and may have advantages over split-virion formulations in the elderly. We tested a plant-made VLP vaccine candidate bearing...

12.

Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization Assay

Shambaugh C, Azshirvani S, Yu L, Pache J, Lambert S, Zuo F, et al.

Clin Vaccine Immunol . 2017 Oct; 24(12). PMID: 29021302

Neutralizing antibodies specific for respiratory syncytial virus (RSV) represent a major protective mechanism against RSV infection, as demonstrated by the efficacy of the immune-prophylactic monoclonal antibody palivizumab in preventing RSV-associated...

13.

Recent Approaches To Optimize Laboratory Assessment of Antinuclear Antibodies

Tebo A

Clin Vaccine Immunol . 2017 Oct; 24(12). PMID: 29021301

The presence of antinuclear antibodies (ANAs) is a hallmark of a number of systemic autoimmune rheumatic diseases, and testing is usually performed as part of the initial diagnostic workup when...

14.

High-Resolution Epitope Positioning of a Large Collection of Neutralizing and Nonneutralizing Single-Domain Antibodies on the Enzymatic and Binding Subunits of Ricin Toxin

Vance D, Tremblay J, Rong Y, Angalakurthi S, Volkin D, Middaugh C, et al.

Clin Vaccine Immunol . 2017 Oct; 24(12). PMID: 29021300

We previously produced a heavy-chain-only antibody (Ab) VH domain (VH)-displayed phage library from two alpacas that had been immunized with ricin toxoid and nontoxic mixtures of the enzymatic ricin toxin...

15.

Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine...

Sow S, Tapia M, Chen W, Haidara F, Kotloff K, Pasetti M, et al.

Clin Vaccine Immunol . 2017 Oct; 24(12). PMID: 29021299

Reactive immunization with a single-dose cholera vaccine that could rapidly (within days) protect immunologically naive individuals during virgin soil epidemics, when cholera reaches immunologically naive populations that have not experienced...

16.

Identification of Novel Antigens Recognized by Serum Antibodies in Bovine Tuberculosis

Lyashchenko K, Grandison A, Keskinen K, Sikar-Gang A, Lambotte P, Esfandiari J, et al.

Clin Vaccine Immunol . 2017 Oct; 24(12). PMID: 28978510

Bovine tuberculosis (TB), caused by , remains an important zoonotic disease posing a serious threat to livestock and wildlife. The current TB tests relying on cell-mediated and humoral immune responses...

17.

Development of an Extended-Specificity Multiplex Immunoassay for Detection of Streptococcus pneumoniae Serotype-Specific Antigen in Urine by Use of Human Monoclonal Antibodies

Eletu S, Sheppard C, Thomas E, Smith K, Daniel P, Litt D, et al.

Clin Vaccine Immunol . 2017 Oct; 24(12). PMID: 28978509

Current pneumococcal vaccines cover the 10 to 23 most common serotypes of the 92 presently described. However, with the increased usage of pneumococcal-serotype-based vaccines, the risk of serotype replacement and...

18.

Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine

Abbanat D, Davies T, Amsler K, He W, Fae K, Janssen S, et al.

Clin Vaccine Immunol . 2017 Oct; 24(12). PMID: 28971965

The global burden of disease caused by extraintestinal pathogenic (ExPEC) is increasing as the prevalence of multidrug-resistant strains rises. A multivalent ExPEC O-antigen bioconjugate vaccine could have a substantial impact...

19.

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8 T-Cell Responses by Interleukin-12 Plasmid DNA

Li S, Kochar N, Elizaga M, Hay C, Wilson G, Cohen K, et al.

Clin Vaccine Immunol . 2017 Sep; 24(11). PMID: 28931520

The HIV Vaccine Trials Network (HVTN) 087 vaccine trial assessed the effect of increasing doses of pIL-12 (interleukin-12 delivered as plasmid DNA) adjuvant on the immunogenicity of an HIV-1 multiantigen...

20.

Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei

Muruato L, Tapia D, Hatcher C, Kalita M, Brett P, Gregory A, et al.

Clin Vaccine Immunol . 2017 Sep; 24(11). PMID: 28903988

is a Gram-negative, facultative intracellular pathogen that causes the disease melioidosis in humans and other mammals. Respiratory infection with leads to a fulminant and often fatal disease. It has previously...